Embodiments relate to Rifaximin polymorphic, salt, and hydrate forms, methods of producing polymorphic forms and to their use in medicinal preparations and to therapeutic methods using them.
申请公布号
SG192122(A1)
申请公布日期
2013.08.30
申请号
SG20130056494
申请日期
2012.02.10
申请人
SALIX PHARMACEUTICALS, LTD.
发明人
PARENT, STEPHAN;MCQUEEN, LISA;ANDRES, PATRICIA;SCHIELDS, PAUL;WU, YIDUO;DING, FEI;SMIT, JARED P.